25
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Distinguishing Premature Ejaculation from Other Sexual Function Disorders

, MD & , MD, FACS
Pages 54-63 | Published online: 30 Jun 2015

References

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
  • Moreira ED Jr. Help-seeking behaviour for sexual problems: the Global Study of Sexual Attitudes and Behaviors. Int J Clin Pract. 2005; 59(1): 6–16.
  • Shabsigh R, Perelman MA. Differences in perception of the impact of and treatment options for premature ejaculation among men and physicians. J Sex Med. 2006; 3(suppl 1): 58.
  • Lawrence S. When patients won't speak up. Medical Economics. 2005; 82(16): 29,31.
  • Masters W, Johnson V. Human Sexual Inadequacy. Boston, MA: Little Brown and Co; 1970.
  • Halvorsen JG, Metz ME. Sexual dysfunction, Part I: Classification, etiology, and pathogenesis. J Am Board Fam Pract. 1992; 5(1): 51–61.
  • Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007; 51 (3): 816–824.
  • Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999; 281(6): 537–544.
  • Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004; 1 (1): 35–39
  • Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151(1): 54–61.
  • Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishia A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49(6): 822–830.
  • Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999; 11(6): 319–326.
  • Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004; 291 (24): 2978–2984.
  • Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004; 20(5): 607–617.
  • Esposito K, Giugliano F, Martedi E, et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care. 2005; 28(5): 1201–1203.
  • Nandipati KC, Raina R, Agarwal A, Zippe CD. Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management. Drugs Aging. 2006; 23(2): 101–117.
  • Cheitlin MD. Erectile dysfunction: the earliest sign of generalized vascular disease? J Am Coll Cardiol. 2004; 43(2): 185–186.
  • Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003; 89(3): 251–253.
  • Billups KL. Erectile dysfunction as a marker for vascular disease. Curr Urol Rep. 2005; 6(6): 439–444.
  • Kirby M, Jackson G, Simonsen U. Endothelial dysfunction links erectile dysfunction to heart disease. Int J Clin Pract. 2005; 59(2): 225–229.
  • Jackson G. The importance of risk factor reduction in erectile dysfunction. Curr Urol Rep. 2007; 8(6): 463–466.
  • American Urological Association. Management of erectile dysfunction: American Urological Association (AUA) Education and Research, Inc. http://www.auanet.org/. Accessed March 13, 2008.
  • Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol. 1996; 78(2): 257–261.
  • Donatucci C, Eardley I, Buvat J, et al. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification. J Sex Med. 2004; 1(3): 301–309.
  • Carrier S, Brock GB, Pommerville PJ, et al. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. J Sex Med. 2005; 2(5): 685–698.
  • Axilrod AC. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction. Curr Med Res Opin. 2007; 23(12): 3189–3198.
  • Rowland D, Perelman M, Althof S, et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med. 2004; 1: 225–232.
  • Shabsigh R, Rowland D. The Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision as an appropriate diagnostic for premature ejaculation. J Sex Med. 2007; 4(5): 1468–1478.
  • Waldinger MD. Premature ejaculation: state of the art. Urol Clin North Am. 2007; 34(4): 591–599, vii–viii.
  • Montague DK, Jarow J, Broderick G, et al; for the AUA Erectile Dysfunction Guideline Update Panel. AUA guideline on the pharmacologic management of premature ejaculation. J Urol. 2004; 172(1): 290–294
  • World Health Organization. International Statistical Classification of Diseases and Related Health Problems (The) ICD-I0. Tenth Revision. Vol 1. Geneva: World Health Organization; 1992: 355–356.
  • McMahon CG, Abdo C, Incrocci L, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2004; 1(1): 58–65.
  • Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I-Validity of DSM-IV-TR. J Sex Med. 2006; 3: 682–692.
  • Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res. 2003; 15(5): 309–313.
  • Waldinger MD, Zwindermann AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis, lnt J Impot Res. 2004; 16: 369–381.
  • Waldinger MD. An empirical operationalization study of DSM IV diagnostic criteria for premature ejaculation, lnt J Psychiatry Clin Pract. 1998; 2: 287–293.
  • Patrick DL, Althof SE, Pryor JL, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005; 2(3): 358–367.
  • Symonds T, Perelman MA, Althof S, et al. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007; 52(2): 565–573.
  • Symonds T, Perelman M, Althof S, et al. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool, lnt J Impot Res. 2007; 19(5): 521–525.
  • Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med. 2006; 3(3): 465–75.
  • Giuliano F, Patrick DL, Porst H, et al; for the 3004 study group. Premature ejaculation: results from a five-countiy European observational study. Eur Urol. 2007 EPub ahead of print.
  • Rowland DL. Psychophysiology of ejaculatory function and dysfunction. World J Urol. 2005; 23(2): 82–88.
  • Filippi S, Vignozzi L, Vannelli GB, Ledda F, Forti G, Maggi M. Role of oxytocin in the ejaculatory process. J Endocrinol Invest. 2003; 26(suppl 3): 82–86.
  • Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev. 1987; 11(4): 365–389.
  • Giuliano F, Clement P. Physiology of ejaculation: emphasis on serotonergic control. Eur Urol. 2005; 48(3): 408–4l7.
  • Corona G, Petrone L, Mannucci E, et al. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol. 2004; 46(5): 615–622.
  • Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005; 90(12): 6472–6479.
  • Gonen M, Kalkan M, Cenker A, Ozkardes H. Prevalence of premature ejaculation in Turkish men with chronic pelvic pain syndrome. J Androl. 2005; 26(5): 601–603.
  • Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology. 2001; 58(2): 198–202.
  • Shamloul R. Chronic prostatitis in premature ejaculation: a cohort study in 153 men J Sex Med. 2006; 3(1): 150–154.
  • Carson CC, Glasser DB, Laumann EO, West SL, Rosen RC. Prevalence and correlates of premature ejaculation among men aged 40 years and older: a United States nationwide population-based study. J Urol. 2003; 169(suppl 4): 321–322.
  • Symonds T, Robiin D, Hart K, Althof S. How does premature ejaculation impact a man's life? J Sac Marital Ther. 2003; 29(5): 361–370.
  • Semans J. Premature ejaculation: a new approach. S Med J. 1956; 49: 353–358.
  • Master VA, Turek PJ. Ejaculatory physiology and dysfunction. Urol Clin North Am. 2001; 28(2): 363–375.
  • McCabe MP. Evaluation of a cognitive behavior therapy program for people with sexual dysfunction. J Sex Marital Ther. 2001; 27(3): 259–271.
  • Hawton K, Catalan J. Prognostic factors in sex therapy. Behav Res Ther. 1986; 24(4): 377–385.
  • Cooper SE, Rowland DL. Treatment implications of behavioral and psychologic research on premature ejaculation. Curr Sex Health Rep. 2005; 2: 77–81.
  • Wyllie MG, Henry R, Morales A. Practical and effective treatment of premature ejaculation (PE) with a lidocaine-prilocaine spray. Proceedings of the American Urological Association, 98th Annual Meeting; 2003.
  • Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int. 2004; 93(7): 1018–1021.
  • Choi HK, Jung GW, Moon KH, et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology. 2000; 55(2): 257–261.
  • Choi HK, Xin ZC, Choi YD, Lee WH, Mah SY, Kim DK. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res. 1999; 11(5): 261–264.
  • Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician. 2003; 68: 498–504.
  • McMahon CG, Tourna K. Treatment of premature ejaculation with paroxetine hydrochloride, lnt J Impot Res. 1999; 11(5): 241–245.
  • Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol. 1998; 18(4): 274–281.
  • Montejo-González AL, Llorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997; 23(3): 176–194.
  • McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int. 2006; 98(2): 259–272.
  • Pryor JL, Althof SE, Steidle C, et al; for the Dapoxetine Study Group. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: integrated analysis of two randomized, double-blind, placebo-controlled trials. Lancet. 2006; 368(9539): 929–937.
  • Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo- controlled, fixed-dose, randomized study. J Clin Psychopharmacol. 2006; 26(1): 27–31.
  • Salem EA, Wilson SK, Bissada NK, Deik JR, Hellstrom WJ, Cleves MA. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med. 2008; 5(1): 188–193.
  • Grenier G, Byers ES. Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sex Behav. 1995; 24(4): 447–472.
  • Risen CB. A guide to taking a sexual history. Clinical Sexuality. 1995; 18(1): 39–53.
  • Abdo CH. The male sexual quotient: a brief, self-administered questionnaire to assess mele sexual satisfaction. J Sex Med. 2007; 4(2): 382–389.
  • Heruti R, Ashkenazi I, Shochat T, Tekes-Manova D, Justo D. Low scores in the sexual health inventory for men questionnaire may indicate sexual disorders other than erectile dysfunction. J Sex Med. 2005; 2(2): 181–186.
  • Seftel AD, Miner MM, Kloner RA, Althof SE. Office evaluation of male sexual dysfunction. Urol Clin North Am. 2007; 34(4): 463–482, v.
  • Perelman MA. A new combination treatment for premature ejaculation: a sex therapist's perspective. J Sex Med. 2006; 3(6): 1004–1012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.